7 June, 2010
Eurofins Medinet is pleased to announce that it has relocated its China central laboratory operation to a larger, dedicated facility in Shanghai. The relocation to a new facility comes in response to the rapid increase in clinical trials being conducted in the country and the need to meet the special (mainly regulatory) requirements the industry faces in running clinical trials in China.
Eurofins Medinet has been offering central laboratory services in China since 2003 and established its own Central Laboratory facility near Shanghai in May 2008 to support local and global clinical trials. The new facility's proximity to the Shanghai Hongqiao domestic airport facilitates close management of logistics and specimen integrity. Eurofins Medinet is one of the very few international companies to have established a fully-owned and managed Central Laboratory to serve its customers in China. Offering these services in China makes Eurofins Medinet one of the top central laboratory operators in the world, with 6 wholly-owned laboratories across North America, Europe, and Asia.
The Eurofins Medinet Shanghai facility operates using the same procedures and quality standards that are already established and proven in the other Eurofins Medinet facilities. Moreover, the Eurofins Medinet Shanghai laboratory achieved NGSP Level 1 certification in June 2008 and CAP accreditation in May 2009. The Eurofins Medinet local laboratory not only offers a full range of safety parameters but has extended its offering by adding further specialised testing services such as HPLC and ELISA. In 2009, Eurofins Medinet Shanghai supported over 80 investigator sites from several studies throughout the Chinese territory and this number is continuously increasing.
For further information please visit www.eurofinsmedinet.com or www.medinet-china.com or contact:
Eurofins Medinet Shanghai
Stanley Tam, General Manager Eurofins Medinet Singapore and Shanghai
395 Jiang Cheng West Road
Phone: +86 21 6181 7500
Phone: +32-2-769 7383
Notes for the editor:
Eurofins - a global leader in bioanalysis
Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of analytical testing services to clients from a wide range of industries including the pharmaceutical, food and environmental sectors.
With 8,000 staff in more than 150 laboratories across 30 countries, Eurofins offers a portfolio of over 40,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to providing its customers with high quality services, accurate results in time and, if requested, expert advice by its highly qualified staff.
The Eurofins Group is the world leader in food testing and one of the global market leaders in pharmaceuticals and environmental testing. It intends to pursue its dynamic growth strategy and expand both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the NYSE Euronext Paris (ISIN FR0000038259) and Frankfurt (WKN 910 251) Stock Exchanges (Reuters EUFI.LN, Bloomberg ERF FP).
About Eurofins Medinet
Eurofins Medinet provides a full range of central laboratory testing services including safety parameters, biomarker development and analysis, and specialized testing in bioanalysis, pharmacokinetics, microbiology and genomics using its fully standardized and accredited central laboratories in the Netherlands, USA (two laboratories), France, Singapore and China.
This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the data available to the Company as of the date of publication, but no guarantee can be made as to their validity.Information non réglementée
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-20113-eurofins-medinet-shanghai-move_english.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|EUROFINS SCIENTIF||Euronext Paris||484.80 (c)||0.12%||44 189|